Synthetic biscoumarins 1-19 were screened to check their anti-leishmanial activity. Out of nineteen, analogs 2 (IC50 = 46.95 ± 1.23 µM), 4 (IC50 = 63.03 ± 0.20 µM), 5 (IC50 = 41.35 ± 0.51 µM), 6 (IC50 = 35.62 ± 0.15 µM), 7 (IC50 = 75.35 ± 0.35 µM), 10 (IC50 = 82.36 ± 1.93 µM), 11 (IC50 = 76.45 ± 0.13 µM), 16 (IC50 = 59.21 ± 1.00 µM), 18 (IC50 = 75.73 ± 1.54 µM), and 19 (IC50 = 76.43 ± 0.04 µM) exhibited moderate to weak anti-leishmanial potential, if compared with the standard pentamidine (IC50 = 5.09 ± 0.04 µM), whilst rest of the analogs were found to be inactive.
Fazal Rahim, Samreen, Hayat Ullah, Muhammad Imran Fakhri, Uzma Salar, Shahnaz Perveen, Khalid Mohammed Khan and M. Iqbal Choudhary
You can use below filter to find your desired issue